MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

ResMed Inc

Chiusa

SettoreSettore sanitario

259.78 1.9

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

251.28

Massimo

259.96

Metriche Chiave

By Trading Economics

Entrata

-31M

349M

Vendite

-12M

1.3B

P/E

Media del settore

26.391

90.831

Rendimento da dividendi

0.87

Margine di Profitto

26.096

Dipendenti

10,600

EBITDA

-29M

503M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+15.44% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.87%

2.20%

Utili prossimi

29 gen 2026

Prossima data del Dividendo

19 mar 2026

Prossima data del' Ex Dividendo

12 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-193M

38B

Apertura precedente

257.88

Chiusura precedente

259.78

Notizie sul Sentiment di mercato

By Acuity

33%

67%

68 / 361 Classifica in Healthcare

ResMed Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 gen 2026, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 gen 2026, 00:00 UTC

Utili

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 gen 2026, 23:47 UTC

Discorsi di Mercato

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 gen 2026, 23:44 UTC

Discorsi di Mercato

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 gen 2026, 23:39 UTC

Discorsi di Mercato

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 gen 2026, 23:32 UTC

Discorsi di Mercato

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 gen 2026, 22:56 UTC

Acquisizioni, Fusioni, Takeovers

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 gen 2026, 22:53 UTC

Acquisizioni, Fusioni, Takeovers

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 gen 2026, 22:17 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

14 gen 2026, 22:17 UTC

Discorsi di Mercato

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 gen 2026, 22:09 UTC

Utili

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 gen 2026, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Announces Positive Profit Alert for 2025

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Citigroup Acting as Financial Advisor to WuXi XDC

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 gen 2026, 21:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

14 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

14 gen 2026, 21:49 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Makes Cash Offer for BioDlink International

14 gen 2026, 21:13 UTC

Discorsi di Mercato

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 gen 2026, 20:30 UTC

Discorsi di Mercato
Utili

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 gen 2026, 20:13 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 gen 2026, 20:08 UTC

Discorsi di Mercato

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 gen 2026, 19:33 UTC

Discorsi di Mercato

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 gen 2026, 19:06 UTC

Discorsi di Mercato
Utili

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Confronto tra pari

Modifica del prezzo

ResMed Inc Previsione

Obiettivo di Prezzo

By TipRanks

15.44% in crescita

Previsioni per 12 mesi

Media 294 USD  15.44%

Alto 345 USD

Basso 260 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ResMed Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

11 ratings

6

Acquista

5

Mantieni

0

Vendi

Sentiment

By Acuity

68 / 361 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat